Coravia
Coravia is a French mid-sized company committed to developing e-health solutions aimed at making everyday healthcare more proactive.
$21.3M Series B+ ·
Led by NextStage AM · Source: capitalfinance.lesechos.fr
Funding history ↓About Coravia
Recent Funding lists Coravia under Health and bio. It raised $21.3M in a Series B+ round in October 2026, led by NextStage AM, according to capitalfinance.lesechos.fr.
Funding rounds
- Series B+ · $21.3M
NNextStage AM (lead)
Source: capitalfinance.lesechos.fr - Website created
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Coravia: questions and answers
- How much has Coravia raised?
- Coravia has raised $21.3M in one sourced round on record (Series B+), announced October 15, 2026.
- Who invested in Coravia?
- Investors on record for Coravia: NextStage AM. NextStage AM led its latest sourced round.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/coravia (get a free API key).